Spain advances in paediatric clinical research through international projects based on public-private partnerships

There are currently more than 600 clinical trials underway for children and adolescents in Spain, almost half of them focused on rare diseases. The Spanish Network of Paediatric Clinical Trials, the Hospital Sant Joan de Déu Barcelona and Farmaindustria organise a conference on the value of international collaboration in this field. Source: Farmaindustria.es Spain is […]

Health sector awaits upcoming regulatory changes: ‘It’s a critical time’.

The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. That was the title of the 5th Symposium of the Healthcare Observatory, organised by EL ESPAÑOL and Invertia. Throughout the four days of this forum, the legislative reforms in […]

Europe streamlines access to clinical trial information

The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial applications in the EU for trial sponsors and regulators. It includes a searchable public database for healthcare professionals, patients and the general public to provide a high level of […]

Patient safety, a pharmaceutical industry commitment throughout the life of a medicine

From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO recalls the importance of safe diagnosis. Farmaindustria.es It is through diagnosis that it is possible to know what is wrong with a patient. To achieve this, patients, healthcare professionals […]

Pharmaceutical companies at the forefront of adopting AI across the entire drug lifecycle

Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum.   Farmaindustria.es Artificial intelligence (AI) is a true revolution that has reached all sectors, but the pharmaceutical sector is at the forefront, as corroborated by the World Economic Forum’s annual report on The 10 Emerging Technologies to Address […]

The ‘Draghi Report’ recognises the pharmaceutical industry as a strategic pillar in Europe that should be strengthened.

The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of the world, especially in the areas of orphan drugs and advanced therapies. Farmaindustria.es The innovative pharmaceutical industry has welcomed the so-called ‘Draghi Report’, presented on Monday by the European […]

Innovative leadership, productive capacity and the ability to drive the country’s economic and social growth make the pharmaceutical industry an essential strategic sector.

The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry in Spain. The Secretary of State for Health, Javier Padilla, talks about the forthcoming publication of the Strategy for the pharmaceutical industry in Spain, which will be published in […]

THE VALUE OF BRAND-NAME DRUGS

    1 THE BRAND-NAME DRUG COSTS THE SAME AS ITS GENERIC DRUG Farmaindustria.es Brand-name drugs are at the same price as generic drugs in Spain. The explanation is that, in the NHS, the reference price system equals the price of original and generic presentations. In our country, more than 82% of the drugs dispensed in […]

The innovative pharmaceutical industry maintains its role as a leading sector in R&D investment and exports in Europe, but loses positions worldwide, surpassed by the USA and now also by China.

For the first time, China has overtaken Europe as the creator of new active ingredients, with 25 compared to the 17 of the old continent, and far from the USA, which had already snatched the crown in the 2000s. The sector invests 50 billion euros in research, directly employs 900,000 people and produces almost 400 […]

Medicines as a strategic asset

EL PAÍS and Farmaindustria address the tasks pending to achieve autonomy in the manufacture of pharmaceuticals. Elpais.com Spain stands out for its strong pharmaceutical industry. It has 174 production plants, of which 106 are dedicated to medicines for human use and 13 to biological products. This ecosystem generates 51,000 direct and indirect jobs, with pharmaceuticals […]